COVID-19 and Cerebrovascular Disease

Christina Catherine, Julia Veitinger, Sherry H.Y. Chou*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

COVID-19 has been associated with numerous neurological complications, with acute cerebrovascular disease being one of the most devastating complications. Ischemic stroke is the most common cerebrovascular complication of COVID-19, affecting between 1 and 6% of all patients. Underlying mechanisms for COVID-related ischemic strokes are thought to be due to vasculopathy, endotheliopathy, direct invasion of the arterial wall, and platelet activation. Other COVID-19-associated cerebrovascular complications include hemorrhagic stroke, cerebral microbleeds, posterior reversible encephalopathy syndrome, reversible cerebral vasoconstriction syndrome, cerebral venous sinus thrombosis, and subarachnoid hemorrhage. This article discusses the incidence of these cerebrovascular complications, risk factors, management strategies, prognosis and future research directions, as well as considerations in pregnancy-related cerebrovascular events in the setting of COVID-19.

Original languageEnglish (US)
Pages (from-to)219-228
Number of pages10
JournalSeminars in Neurology
Volume43
Issue number2
DOIs
StatePublished - Jun 28 2023

Keywords

  • COVID-19
  • cerebral microbleeds
  • stroke
  • venous sinus thrombosis

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Fingerprint

Dive into the research topics of 'COVID-19 and Cerebrovascular Disease'. Together they form a unique fingerprint.

Cite this